Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology.

× No keyword cloud information.

5 in total

1. Key role of nuclear medicine in bringing imaging biomarkers into clinical practice.

Authors: Ignasi Carrió
Journal: Eur J Nucl Med Mol Imaging Date: 2009-12 Impact factor: 9.236

2. Most of the Intended Management Changes After ⁶⁸Ga-DOTATATE PET/CT Are Implemented.

Authors: Jeremie Calais; Johannes Czernin; Matthias Eiber; Wolfgang P Fendler; Jeannine Gartmann; Anthony P Heaney; Andrew E Hendifar; Joseph R Pisegna; J Randolph Hecht; Edward M Wolin; Roger Slavik; Pawan Gupta; Andrew Quon; Christiaan Schiepers; Martin S Allen-Auerbach; Ken Herrmann
Journal: J Nucl Med Date: 2017-05-04 Impact factor: 10.057

3. PET/CT-Guided Interventions in Oncology Patients: A Nursing Perspective.

Authors: Julia S Taylor; Leah Keller; Majid Maybody
Journal: J Radiol Nurs Date: 2017-05-20

4. Impact of ⁶⁸Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.

Authors: Jeremie Calais; Wolfgang P Fendler; Matthias Eiber; Jeannine Gartmann; Fang-I Chu; Nicholas G Nickols; Robert E Reiter; Matthew B Rettig; Leonard S Marks; Thomas E Ahlering; Linda M Huynh; Roger Slavik; Pawan Gupta; Andrew Quon; Martin S Allen-Auerbach; Johannes Czernin; Ken Herrmann
Journal: J Nucl Med Date: 2017-12-14 Impact factor: 10.057

5. Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

Authors: Boris Sepesi; Daniel P Raymond; Marek Polomsky; Thomas J Watson; Virginia R Litle; Carolyn E Jones; Rui Hu; Xing Qiu; Jeffrey H Peters
Journal: J Gastrointest Surg Date: 2009-10-01 Impact factor: 3.452

5 in total

Practice-based evidence of the beneficial impact of positron emission tomography in clinical oncology.

1. Key role of nuclear medicine in bringing imaging biomarkers into clinical practice.

2. Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented.

3. PET/CT-Guided Interventions in Oncology Patients: A Nursing Perspective.

4. Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.

5. Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

2. Most of the Intended Management Changes After ⁶⁸Ga-DOTATATE PET/CT Are Implemented.

4. Impact of ⁶⁸Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.